Cholangiocarcinoma (CCA) originates from the epithelium of the bile duct and is highly
malignant with a poor prognosis. Radical resection is the only treatment option to completely …

Background Perihilar cholangiocarcinoma (phCCC) is a dismal malignancy. There is no
consensus regarding the best treatment for patients with unresectable phCCC. The present …

Biliary tract cancers (BTC) are rare and aggressive tumors with poor prognosis. Radical
surgery offers the best chance for cure; however, most patients present with unresectable …

Objective: To evaluate each arm independently and compare adjuvant gemcitabine (GEM)
and S-1 chemotherapy after major hepatectomy (hemihepatectomy or trisectionectomy) for …

Gallbladder cancer (GBC) is rare in Western populations and data about treatment and
outcomes are scarce. This study aims to analyze survival and identify opportunities for …

Biliary tract cancer, which includes intrahepatic cholangiocarcinoma, extrahepatic bile duct
cancer, gallbladder cancer, and ampullary cancer, is an intractable disease with a dismal …

Background Surgical resection is the only curative strategy for perihilar cholangiocarcinoma
(PHC), but recurrence rates are high even after purported curative resection. This study …

Background Treatment with neoadjuvant chemoradiotherapy followed by liver
transplantation yields promising results in perihilar cholangiocarcinoma (PH-CCA). This …

Background and objective: Gallbladder cancer (GBC) is a rare malignancy in the Nordic
countries and no common Nordic treatment guidelines exist. This study aimed to …

Abstract Background/Aim We previously demonstrated that inflammatory cytokine interleukin-
6 (IL-6) was produced during cancer progression, worked together with transforming growth …